Secondary cutaneous aspergillosis disseminated from the lungs of a patient with asthma on 1 month steroid treatment.
Cutaneous aspergillosis is very rare and occurs predominantly in transplant patients. Here, we report a 55-year-old female who underwent steroid treatment for 1 month and developed secondary cutaneous aspergillosis from pulmonary aspergillosis due to Aspergillus fumigatus.
Kim
Chan Woong
CW
Department of Emergency Medicine, Chung-Ang University Yong-San Hospital, Seoul 140-757, South Korea.
Seo
Jae Seung
JS
Kim
Mi-Kyung
MK
Jun
Eun Ju
EJ
Choi
Jae Chol
JC
Choi
Byoung Whui
BW
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use; D001232:Aspergillus fumigatus / Q000302:isolation & purification*; D001249:Asthma / Q000188:drug therapy / Q000382:microbiology*; D003881:Dermatomycoses / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D005260:Female; D006801:Humans; D008775:Methylprednisolone / Q000627:therapeutic use*; D008875:Middle Aged; D055732:Pulmonary Aspergillosis / Q000188:drug therapy / Q000382:microbiology*
D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D008775:Methylprednisolone